Results 111 to 120 of about 3,259,253 (212)

Neuropeptide Y Receptor Binding Profiles of Endogenous Ligands in the Presence and Absence of Sodium: A Panoramic View. [PDF]

ACS Pharmacol Transl Sci
Gattor AO, Schettler F, Erl J, Brunner T, Wegener J, Koch P, Keller M.   +6 more
europepmc   +1 more source

Development of dual SST₂/SST₅ targeting radioligands through rational structural design. [PDF]

RSC Med Chem
Spinnler F, Del Pozzo L, Bohrmann L, Zanger S, Blum NK, Brendel M, Schulz S, Mansi R, Fani M.   +8 more
europepmc   +1 more source

Three Distinct Binding Modes Govern High-Affinity Ligand Interactions with Amyloid Fibrils. [PDF]

Biochemistry
Chisholm TS.
europepmc   +1 more source

Development of pH-Sensitive β‑Adrenergic Receptor Antagonists. [PDF]

ACS Pharmacol Transl Sci
Braun T, Pröll T, Weißing N, Hübner H, Gmeiner P.   +4 more
europepmc   +1 more source

SOM3355: a unique pharmacological profile combining VMAT1 inhibition, VMAT2-mediated dopamine modulation, and β₁-adrenergic antagonism for the treatment of movement and neuropsychiatric disorders. [PDF]

Front Pharmacol
Turilli-Ghisolfi ES, Støve SI, Huertas O, Kråkenes TA, Teigen K, Panigone S, Medori R.   +6 more
europepmc   +1 more source

Effects of contaminant radioactivity on results of 125I-radioligand assay.

Clinical Chemistry, 1979
L. Witherspoon, S. Shuler, M. M. García, Louise A. Zollinger   +3 more
semanticscholar   +1 more source

Deciphering the phenotypic responses to ¹⁷⁷Lu-based radioligand therapy to identify efficacious combinations. [PDF]

Eur J Nucl Med Mol Imaging
Ranzani M, Cicconi A, Sastre-Moreno G, Thapa A, Simon E, Reber J, Barlow J, Boursier ML, Cerutti A, Deberle L, Del Pozzo L, Elinati E, Geo L, Grinkevich V, Hartnagel C, Hindupur SK, Koler K, Menon S, Neves J, Schacher B, Shao N, Rajendra E, Reschke M, Schmelzle T, Smith GCM, Robinson HMR, Cortes-Cros M.   +26 more
europepmc   +1 more source

Synthesis and Characterization of Tritium-Labeled Neuropeptide Y Y₅ Receptor Ligands Derived From CGP71683A. [PDF]

Arch Pharm (Weinheim)
Schettler F, Koch P, Keller M.
europepmc   +1 more source

The Selectivity Implications of Docking Libraries with Greater and Lesser Similarities to Bio-like Molecules. [PDF]

J Med Chem
Hall BW, Sakamoto K, Huang XP, Irwin JJ, Shoichet BK, Roth BL.   +5 more
europepmc   +1 more source

The use of a modified [3H]4-DAMP radioligand binding assay with increased selectivity for muscarinic M3 receptor shows that cortical CHRM3 levels are not altered in mood disorders.

Progress in Neuro-psychopharmacology and Biological Psychiatry, 2013
W. Jeon, A. Gibbons, B. Dean
semanticscholar   +1 more source